JOHNSON JOHN

Track

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 17% 68% 82%
Transactions
12 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
JOHNSON JOHN's trades of Xeris Biopharma Holdings Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US AxoGen Inc (AXGN)
Transaction date
Sale
Price
210.71
Quantity 54,308 +10.6%
Value US$847,774
US AxoGen Inc (AXGN)
Transaction date
Proposed sale
Price
43.26
Quantity 11,050
Value US$477,971
US AxoGen Inc (AXGN)
Transaction date
Sale
Price
29.98
Quantity 13,141 -100.0%
Value US$393,993
US AxoGen Inc (AXGN)
Transaction date
Sale
Price
29.98
Quantity 8,545 -39.4%
Value US$256,196
US AxoGen Inc (AXGN)
Transaction date
Proposed sale
Price
29.98
Quantity 21,686
Value US$650,186
US AxoGen Inc (AXGN)
Transaction date
Sale
Price
31.22
Quantity 11,891 -47.5%
Value US$371,273
US AxoGen Inc (AXGN)
Transaction date
Sale
Price
31.26
Quantity 11,802 -47.3%
Value US$368,931
US AxoGen Inc (AXGN)
Transaction date
Proposed sale
Price
31.24
Quantity 23,693
Value US$740,207
US AxoGen Inc (AXGN)
Transaction date
Sale
Price
10.61
Quantity 4,073 -14.0%
Value US$43,215
GB Senior PLC (SNR)
Transaction date
Sale
Price
1.73
Quantity 72,467
Value £125,549
GB Senior PLC (SNR)
Transaction date
Sale
Price
1.23
Quantity 13,057
Value £16,069
GB Senior PLC (SNR)
Transaction date
Sale
Price
1.17
Quantity 11,982
Value £13,995
GB Senior PLC (SNR)
Transaction date
Sale
Price
1.41
Quantity 17,695
Value £24,897
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-05 2026-06-04
PlS Planned sale
54,281 +48.2%
400.52
US$1,397,192 		54,281 +48.2% 400.52 US$1,397,192
2026-06-04 2026-06-04
PrS Proposed sale
69,528
272.12
US$544,363 		69,528 272.12 US$544,363
2026-05-08 2026-05-07
US AxoGen Inc (AXGN)
S Sale
54,308 +10.6%
210.71
US$847,774 		54,308 +10.6% 210.71 US$847,774
2026-05-07 2026-05-07
US AxoGen Inc (AXGN)
PrS Proposed sale
11,050
43.26
US$477,971 		11,050 43.26 US$477,971
2025-12-19 2025-12-19
PrS Proposed sale
135,402
7.22
US$977,034 		135,402 7.22 US$977,034
2025-12-19 2025-12-19
S Sale
135,400 -16.2%
7.22
US$977,019 		135,400 -16.2% 7.22 US$977,019
2025-12-10 2025-12-09
US AxoGen Inc (AXGN)
S Sale
13,141 -100.0%
29.98
US$393,993 		13,141 -100.0% 29.98 US$393,993
2025-12-10 2025-12-09
US AxoGen Inc (AXGN)
S Sale
8,545 -39.4%
29.98
US$256,196 		8,545 -39.4% 29.98 US$256,196
2025-12-09 2025-12-09
US AxoGen Inc (AXGN)
PrS Proposed sale
21,686
29.98
US$650,186 		21,686 29.98 US$650,186
2025-12-10 2025-12-08
US AxoGen Inc (AXGN)
S Sale
11,891 -47.5%
31.22
US$371,273 		11,891 -47.5% 31.22 US$371,273
2025-12-10 2025-12-08
US AxoGen Inc (AXGN)
S Sale
11,802 -47.3%
31.26
US$368,931 		11,802 -47.3% 31.26 US$368,931
2025-12-08 2025-12-08
US AxoGen Inc (AXGN)
PrS Proposed sale
23,693
31.24
US$740,207 		23,693 31.24 US$740,207
2025-08-15 2025-08-13
S Sale
107,500 -11.4%
7.32
US$786,459 		107,500 -11.4% 7.32 US$786,459
2025-08-13 2025-08-13
PrS Proposed sale
107,500
7.32
US$786,452 		107,500 7.32 US$786,452
2025-06-11 2025-06-09
US AxoGen Inc (AXGN)
S Sale
4,073 -14.0%
10.61
US$43,215 		4,073 -14.0% 10.61 US$43,215
2024-03-21 2024-03-19
GB Senior PLC (SNR)
S Sale
72,467
1.73
£125,549 		72,467 1.73 £125,549
2022-03-09 2022-03-08
GB Senior PLC (SNR)
S Sale
13,057
1.23
£16,069 		13,057 1.23 £16,069
2021-09-23 2021-09-22
B Purchase
6,633
0.30
£1,990 		6,633 0.30 £1,990
2021-03-18 2021-03-18
GB Senior PLC (SNR)
S Sale
11,982
1.17
£13,995 		11,982 1.17 £13,995
2020-03-10 2020-03-06
GB Senior PLC (SNR)
S Sale
17,695
1.41
£24,897 		17,695 1.41 £24,897
2019-08-15 2019-08-15
B Purchase
13,655
0.73
£9,900 		13,655 0.73 £9,900
2019-07-02 2019-06-27
S Sale
13,000 -25.8%
5.57
US$72,441 		13,000 -25.8% 5.57 US$72,441